Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Realizing the clinical potential of ischemic preconditioning and postconditioning

Nature Clinical Practice Cardiovascular Medicine volume 2, pages 568–575 (2005)Cite this article

Abstract

After an acute myocardial infarction (AMI), early reperfusion by thrombolysis or primary percutaneous coronary intervention remains the most-effective strategy for limiting the size of an evolving infarct. The mortality from AMI, however, remains significant, due partly to the lethal reperfusion injury that occurs on reperfusing the ischemic myocardium. Novel cardioprotective strategies are required to target this form of injury. In ischemic preconditioning transient, nonlethal episodes of myocardial ischemia and reperfusion before the index ischemic episode reduce infarct size. The cardioprotective potential of ischemic preconditioning has not been realized in clinical practice because it necessitates an intervention applied before the onset of AMI, which is difficult to predict. A more-amenable approach to cardioprotection is to intervene at the onset of reperfusion, the timing of which is under the control of the operator. In this regard, ischemic postconditioning, in which transient episodes of myocardial ischemia and reperfusion administered at the onset of reperfusion reduce infarct size, constitutes one such intervention. Interestingly, studies suggest that ischemic preconditioning and postconditioning activate the same signaling pathway at the time of reperfusion, thereby offering a common target for cardioprotection. Therefore, the pharmacologic recruitment of this signaling pathway at the time of myocardial reperfusion might allow one to harness the cardioprotective potential of ischemic preconditioning and postconditioning. In this review, we discuss the potential application of ischemic preconditioning and postconditioning in the clinical arena of myocardial ischemia and reperfusion, and examine the common signaling pathways by which this might be achieved.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A schematic representation demonstrating a common pathway of cardioprotection at the time of myocardial reperfusion involving the activation of the reperfusion injury salvage kinase pathway, inhibition of mitochondrial permeability transition pore opening and reduction in myocardial infarct size.

Similar content being viewed by others

References

  1. Fuster V (1999) Epidemic of cardiovascular disease and stroke: the three main challenges. Presented at the 71st scientific sessions of the American Heart Association. Dallas, Texas. Circulation 99: 1132–1137

    Article  CAS  Google Scholar 

  2. Braunwald E and Kloner RA (1985) Myocardial reperfusion: a double-edged sword? J Clin Invest 76: 1713–1719

    Article  CAS  Google Scholar 

  3. Bolli R et al. (2004) Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 95: 125–134

    Article  CAS  Google Scholar 

  4. Kloner RA and Rezkalla SH (2004) Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol 44: 276–286

    Article  Google Scholar 

  5. Kloner RA et al. (1998) Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation 97: 1848–1867

    Article  CAS  Google Scholar 

  6. Murry CE (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124–1136

    Article  CAS  Google Scholar 

  7. Zhao ZQ et al. (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579–H588

    Article  CAS  Google Scholar 

  8. Yellon DM and Downey JM (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83: 1113–1151

    Article  CAS  Google Scholar 

  9. Marber MS et al. (1993) Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264–1272

    Article  CAS  Google Scholar 

  10. Garlid KD et al. (1997) Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81: 1072–1082

    Article  CAS  Google Scholar 

  11. Vanden Hoek TL et al. (1998) Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 273: 18092–18098

    Article  CAS  Google Scholar 

  12. Hausenloy DJ et al. (2002) Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55: 534–543

    Article  CAS  Google Scholar 

  13. Ikonomidis JS et al. (1994) Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res 28: 1285–1291

    Article  CAS  Google Scholar 

  14. Walker DM et al. (1995) Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 27: 1349–1357

    Article  CAS  Google Scholar 

  15. Williams DO et al. (1985) Adaptation to the stress of tachycardia in patients with coronary artery disease: insight into the mechanism of the warm-up phenomenon. Circulation 71: 687–692

    Article  CAS  Google Scholar 

  16. Rezkalla SH and Kloner RA (2004) Ischemic preconditioning and preinfarction angina in the clinical arena. Nat Clin Pract Cardiovasc Med 1: 96–102

    Article  Google Scholar 

  17. Deutsch E et al. (1990) Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 82: 2044–2051

    Article  CAS  Google Scholar 

  18. Jenkins DP et al. (1995) Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice. Cardiovasc Drugs Ther 9: 739–747

    Article  CAS  Google Scholar 

  19. Moolman JA et al. (1997) Ischaemic preconditioning does not protect hypertrophied myocardium against ischaemia. S Afr Med J 87 (Suppl 3): C151–C156

    PubMed  Google Scholar 

  20. Schulman D et al. (2001) Effect of aging on the ability of preconditioning to protect rat hearts from ischemia–reperfusion injury. Am J Physiol Heart Circ Physiol 281: H1630–H1636

    Article  CAS  Google Scholar 

  21. Tsang A et al. (2005) Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 54: 2360–2364

    Article  CAS  Google Scholar 

  22. IONA Study group (2002) Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359: 1269–1275

  23. Ono H et al. (2004) Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J 148: E15

    Article  Google Scholar 

  24. Avkiran M and Marber MS (2002) Na+/H+ exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol 39: 747–753

    Article  CAS  Google Scholar 

  25. Bolli R (2003) The role of sodium–hydrogen ion exchange in patients undergoing coronary artery bypass grafting. J Card Surg 18 (Suppl 1): 21–26

    Article  Google Scholar 

  26. Quintana M et al. (2004) Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent. Am J Cardiovasc Drugs 4: 159–167

    Article  CAS  Google Scholar 

  27. Dana A et al. (1998) Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned state. J Am Coll Cardiol 31: 1142–1149

    Article  CAS  Google Scholar 

  28. Yellon DM and Baxter GF (1999) Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury? Trends Cardiovasc Med 9: 245–249

    Article  CAS  Google Scholar 

  29. Hausenloy DJ and Yellon DM (2004) New directions for protecting the heart against ischaemia–reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 61: 448–460

    Article  CAS  Google Scholar 

  30. Heusch G (2004) Postconditioning: old wine in a new bottle? J Am Coll Cardiol 44: 1111–1112

    Article  Google Scholar 

  31. Tsang A (2004) Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95: 230–232

    Article  CAS  Google Scholar 

  32. Okamoto F et al. (1986) Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg 92: 613–620

    CAS  PubMed  Google Scholar 

  33. Sato H et al. (1997) Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation. Ann Thorac Surg 64: 1099–1107

    Article  CAS  Google Scholar 

  34. Yang XM et al. (2004) Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44: 1103–1110

    Article  Google Scholar 

  35. Argaud L et al. (2005) Postconditioning inhibits mitochondrial permeability transition. Circulation 111: 194–197

    Article  CAS  Google Scholar 

  36. Hausenloy DJ et al. (2005) The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15: 69–75

    Article  CAS  Google Scholar 

  37. Downey JM and Cohen MV (2005) We think we see a pattern emerging here. Circulation 111: 120–121

    Article  Google Scholar 

  38. Hausenloy DJ et al. (2005) Ischemic preconditioning protects by activating pro-survival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288: H971–H976

    Article  CAS  Google Scholar 

  39. Griffiths EJ and Halestrap AP (1995) Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307 (Pt 1): 93–98

    Article  CAS  Google Scholar 

  40. Hausenloy DJ and Yellon DM (2003) The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35: 339–341

    Article  CAS  Google Scholar 

  41. Jonassen AK (2001) Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89: 1191–1198

    Article  CAS  Google Scholar 

  42. Bell RM and Yellon DM (2003) Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J Am Coll Cardiol 41: 508–515

    Article  CAS  Google Scholar 

  43. Bullard AJ et al. (2005) Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo. Basic Res Cardiol [10.1007/s00395-005-0537-4]

  44. Bose AK et al. (2005) Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 54: 146–151

    Article  CAS  Google Scholar 

  45. Mensah K et al. (2005) Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 45: 1287–1291

    Article  CAS  Google Scholar 

  46. Hausenloy DJ et al. (2003) Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia–reperfusion injury. Cardiovasc Res 60: 617–625

    Article  CAS  Google Scholar 

  47. Halkos ME et al. (2004) Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 78: 961–969

    Article  Google Scholar 

  48. Fath-Ordoubadi F and Beatt KJ (1997) Glucose–insulin–potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 96: 1152–1156

    Article  CAS  Google Scholar 

  49. Mehta SR et al. (2005) Effect of glucose–insulin–potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE–ECLA randomized controlled trial. JAMA 293: 437–446

    Article  Google Scholar 

  50. Apstein CS and Opie LH (2005) A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J 26: 956–959

    Article  Google Scholar 

  51. Ehrenreich H et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8: 495–505

    Article  CAS  Google Scholar 

  52. Nikolaidis LA et al. (2004) Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation 109: 962–965

    Article  CAS  Google Scholar 

  53. Kin H et al. (2004) Postconditioning attenuates myocardial ischemia–reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62: 74–85

    Article  CAS  Google Scholar 

  54. Galagudza M et al. (2004) Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. Eur J Cardiothorac Surg 25: 1006–1010

    Article  Google Scholar 

  55. Sun K et al. (2004) Role of mitochondria in cell apoptosis during hepatic ischemia–reperfusion injury and protective effect of ischemic postconditioning. World J Gastroenterol 10: 1934–1938

    Article  Google Scholar 

  56. Yang XM et al. (2005) Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 100: 57–63

    Article  CAS  Google Scholar 

  57. Chiari PC et al. (2005) Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 102: 102–109

    Article  CAS  Google Scholar 

  58. Serviddio G et al. (2005) Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia–reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion. FASEB J 19: 354–361

    Article  CAS  Google Scholar 

  59. Sun HY et al. (2005) Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 288: H1900–H1908

    Article  CAS  Google Scholar 

  60. Darling CE et al. (2005) 'Postconditioning' via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK 1/2. Am J Physiol Heart Circ Physiol [10.1152/ajpheart.00055.2005]

  61. Kin H et al. (2005) Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 67: 124–133

    Article  CAS  Google Scholar 

  62. Kerendi F et al. (2005) Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res Cardiol [10.1007/s00395-005-0539-2]

Download references

Acknowledgements

We thank the British Heart Foundation for continuing support.

Author information

Authors and Affiliations

  1. Director of Hatter Institute and Centre for Cardiology, University College London Hospital and Medical School, London, UK

    Derek M Yellon

  2. a Trainee Cardiologist and Postdoctoral Research Fellow at the Hatter Institute and Centre for Cardiology, University College London Hospital and Medical School, London, UK

    Derek J Hausenloy

Authors
  1. Derek M Yellon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Derek J Hausenloy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Derek M Yellon.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yellon, D., Hausenloy, D. Realizing the clinical potential of ischemic preconditioning and postconditioning. Nat Rev Cardiol 2, 568–575 (2005). https://doi.org/10.1038/ncpcardio0346

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0346

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing